These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 2597180
1. Catalytic effect of serum albumin on the o-rearrangement of N-sulfooxy-2-acetylaminofluorene, a potential hepatocarcinogen in the rat, to nonmutagenic sulfuric acid esters of o-amidofluorenols. Smith BA, Gutmann HR, Springfield JR. Biochem Pharmacol; 1989 Nov 15; 38(22):3987-94. PubMed ID: 2597180 [Abstract] [Full Text] [Related]
2. Effect of bovine serum albumin on the extent of ortho rearrangement of N-(sulfooxy)-2-fluorenylacetamide and of enzymatically activated N-hydroxy-2-fluorenylacetamide and on the binding of reactive esters to nucleic acids. Kolanczyk RC, Gutmann HR, Rutks IR. Chem Res Toxicol; 1992 Nov 15; 5(2):274-9. PubMed ID: 1643258 [Abstract] [Full Text] [Related]
3. The catalytic effect of bovine serum albumin on the ortho rearrangement of the potential ultimate carcinogen, N-(sulfooxy)-2-(acetylamino)fluorene, generated enzymatically from N-hydroxy-2-(acetylamino)fluorene and evidence for substrate specificity of the enzymatic sulfonation of arylhydroxamic acids. Kolanczyk RC, Rutks IR, Gutmann HR. Chem Res Toxicol; 1991 Nov 15; 4(2):187-94. PubMed ID: 1782347 [Abstract] [Full Text] [Related]
4. Solvolysis and metabolic degradation, by rat liver, of the ultimate carcinogen, N-sulfonoxy-2-acetylaminofluorene. Smith BA, Springfield JR, Gutmann HR. Mol Pharmacol; 1987 Apr 15; 31(4):438-45. PubMed ID: 3574289 [Abstract] [Full Text] [Related]
5. Interaction of the synthetic ultimate carcinogens, N-sulfonoxy- and N-acetoxy-2-acetylaminofluorene, and of enzymatically activated N-hydroxy-2-acetylaminofluorene with nucleophiles. Smith BA, Springfield JR, Gutmann HR. Carcinogenesis; 1986 Mar 15; 7(3):405-11. PubMed ID: 3512117 [Abstract] [Full Text] [Related]
9. N-sulfoöxy-2-aminofluorene is the major ultimate electrophilic and carcinogenic metabolite of N-hydroxy-2-acetylaminofluorene in the livers of infant male C57BL/6J x C3H/HeJ F1 (B6C3F1) mice. Lai CC, Miller JA, Miller EC, Liem A. Carcinogenesis; 1985 Jul 15; 6(7):1037-45. PubMed ID: 3860305 [Abstract] [Full Text] [Related]
10. Reaction product inactivation of aryl sulfotransferase IV following electrophilic substitution by the sulfuric acid ester of N-hydroxy-2-acetylaminofluorene. Ringer DP, Norton TR, Self RR. Carcinogenesis; 1992 Jan 15; 13(1):107-12. PubMed ID: 1733562 [Abstract] [Full Text] [Related]
11. Correlation between clastogenicity and promotion activity in liver carcinogenesis by N-hydroxy-2-acetylaminofluorene, N-hydroxy-4'-fluoro-4-acetylaminobiphenyl and N-hydroxy-4-acetylaminobiphenyl. van de Poll ML, van der Hulst DA, Tates AD, Meerman JH. Carcinogenesis; 1990 Feb 15; 11(2):333-9. PubMed ID: 2302760 [Abstract] [Full Text] [Related]
12. Effect of glutathione depletion on the hepatotoxicity and covalent binding rat liver macromolecules of N-hydroxy-2-acetylaminofluorene. Meerman JH, Tijdens RB. Cancer Res; 1985 Mar 15; 45(3):1132-9. PubMed ID: 2578873 [Abstract] [Full Text] [Related]
13. New 9-stubstituted 3-N,O-diacetylhydroxylaminofluorenes: enhanced electrophilicity and mutagenicity. Derivatives of fluorene. 38. Cole CA, Pan HL, Fletcher TL. Cancer Lett; 1980 Mar 15; 9(1):61-6. PubMed ID: 7370977 [Abstract] [Full Text] [Related]
14. Role of sulfation in the formation of DNA adducts from N-hydroxy-2-acetylaminofluorene in rat liver in vivo. Inhibition of N-acetylated aminofluorene adduct formation by pentachlorophenol. Meerman JH, Beland FA, Mulder GJ. Carcinogenesis; 1981 Mar 15; 2(5):413-6. PubMed ID: 7273322 [Abstract] [Full Text] [Related]
15. Self-catalyzed irreversible inactivation of rat hepatic aryl sulfotransferase IV by N-hydroxy-2-acetylaminofluorene. Mangold BL, Erickson J, Lohr C, McCann DJ, Mangold JB. Carcinogenesis; 1990 Sep 15; 11(9):1563-7. PubMed ID: 2401045 [Abstract] [Full Text] [Related]
16. Formation of DNA adducts from N-acetoxy-2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene in rat hemopoietic tissues in vivo. Vu VT, Grantham PH, Roller PP, Hankins WD, Wirth PJ, Thorgeirsson SS. Cancer Res; 1986 Jan 15; 46(1):233-8. PubMed ID: 3940194 [Abstract] [Full Text] [Related]
17. Aminofluorene-DNA adduct formation in Salmonella typhimurium exposed to the carcinogen N-hydroxy-2-acetylaminofluorene. Beranek DT, White GL, Heflich RH, Beland FA. Proc Natl Acad Sci U S A; 1982 Sep 15; 79(17):5175-8. PubMed ID: 6752940 [Abstract] [Full Text] [Related]
18. Initiation of hepatocarcinogenesis in infant male B6C3F1 mice by N-hydroxy-2-aminofluorene or N-hydroxy-2-acetylaminofluorene depends primarily on metabolism to N-sulfooxy-2-aminofluorene and formation of DNA-(deoxyguanosin-8-yl)-2-aminofluorene adducts. Lai CC, Miller EC, Miller JA, Liem A. Carcinogenesis; 1987 Mar 15; 8(3):471-8. PubMed ID: 3815742 [Abstract] [Full Text] [Related]
19. The role of N-sulfation in the N-hydroxy-2-acetylaminofluorene-mediated outgrowth of diethylnitrosamine-initiated hepatocytes to gamma-glutamyltranspeptidase-positive foci in male rat liver. Kroese ED, van de Poll ML, Mulder GJ, Meerman JH. Carcinogenesis; 1988 Nov 15; 9(11):1953-8. PubMed ID: 2902938 [Abstract] [Full Text] [Related]
20. Covalent binding of 2-acetylaminofluorene, 2-aminofluorene, and N-hydroxy-2-acetylaminofluorene to rat liver nuclear DNA and protein in vivo and in vitro. Stout DL, Hemminki K, Becker FF. Cancer Res; 1980 Oct 15; 40(10):3579-84. PubMed ID: 7438044 [Abstract] [Full Text] [Related] Page: [Next] [New Search]